Research and development of finished dosage forms

Highest demands on formulations and innovation

Grow your brand with added value for patients!

The world´s most trusted brands count on our high excellence in pharmaceutical research and development, building the foundation for our broad and innovative product portfolio. Acting on the needs of our global customers and the everchanging market, we target generics as well as differentiated and innovative products. Whether it´s fewer side effects, a better API absorption or a personalized drug dispensing device, we believe that there are always new ways of smart medicines which better deliver on patients´ needs. This pioneer spirit is driven by our curiosity – the curiosity of each of our employees dedicated to make patients´ lives better. To better understand patients´ needs we are in close and regular collaboration with universities and key opinion leaders of all relevant disciplines.

Our own laboratories, the long-lasting experience of our research & development staff, and our exclusive network of development partners enable us to cover all major indications as well as diverse and innovative dosage forms. We succeed in developing tablets, capsules, modified release formulations, oral and ophthalmic solutions as well as special technologies like patches, inhalers, injectables or personalized devices. Our current portfolio consists of 180 products: 100 dossiers, 40 products under development, and 40 in our pipeline. Every year, we start the development of 10 to 15 promising new products – both niche products and blockbusters – to fuel our sustainable growth. Outstanding intellectual property guidance and quality assurance are the backbone of our Research & Development operations.

Tiefenbacher research and development at a glance

Your benefits of our advanced Research & Development operations

180 +

dossiers developed/ under development

generic and innovative formulations

all major indications

broad spectrum of different dosage forms

180 +

products

generic and innovative formulations

all major indications

broad spectrum of different dosage forms

innovative and digital technologies

FDA approved own laboratory

outstanding intellectual property guidance

highly reliable quality assurance

innovative and digital technologies

FDA approved own laboratory

outstanding intellectual property guidance

highly reliable quality assurance

TIEFENBACHER Laboratories

With advanced technologies to pharmaceuticals of the future

Our FDA approved laboratories in India

The research and development operations for both generic and innovative formulations are supported by our advanced laboratory in Hyderabad, India. TIEFENBACHER LABORATORIES features a GLP/GMP compliant environment on a 32.000 m² sized plant. Most modern techniques and softwares (e. g. inhouse XRD Crystallography and WinNonlin IVIVC simulation tools) are part of the state-of-the-art research & development equipment. Quality control is an integral part of TIEFENBACHER LABORATORIES. It ensures a development process which considers all aspects of quality requirements, customer requirements, transparency, and applying good manufacturing practice – according to national as well as international legislation. The development projects are performed following ICH, EU, USFDA and other international guidelines. This enables us to generate a corresponding documentation for the submission of a marketing authorization application in the EU, in the US, and further international territories. TIEFENBACHER LABORATORIES holds the ISO 14001:2014 and ISO 18001:2015 certifications and was successfully inspected by the German BGV, the Russian MIT and the US FDA authorities.

We are happy to help, get in touch

Do not hesitate to get in touch for more information about our research & development solutions. Our experts are always available to help.
Please contact us by filling out the contact form below and clicking “Send message”. We will follow up with you personally as soon as possible